OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SWAN59

Black Swan Graphene Inc

Specialty ChemicalsVerified

Black Swan Graphene Inc operates with a highly liquid capital structure, as evidenced by a current ratio of 56.53, indicating strong short-term liquidity and minimal reliance on debt financing. The company holds $4.79 million in cash and equivalents, with no long-term debt, and a debt-to-equity ratio of 0.0, suggesting a conservative leverage profile. Despite this, the company reported negative operating and free cash flows of -$529,840 and -$406,900, respectively, indicating ongoing operational cash burn. Profitability metrics are negative, with a return on equity (ROE) of -4.88% and a return on assets (ROA) of -4.84%, both significantly below the typical performance of the specialty chemicals industry. These figures suggest the company is not generating returns for shareholders or effectively utilizing its asset base. The company's operating and net losses of -$687,760 and -$643,380, respectively, further underscore the lack of profitability. The company's revenue is not disclosed in the provided data, and no segment or geographic breakdown is available. This lack of transparency limits the ability to assess revenue concentration or geographic exposure. However, the absence of disclosed segments suggests the company may be in an early stage of development or may not have material operations beyond its core graphene business. The company's growth trajectory is unclear due to the absence of historical revenue data or forward-looking guidance. Analysts have assigned a mean price target of $2.50, with a strong buy recommendation, but this is based on limited data and does not reflect a clear path to profitability or revenue growth. The company's current financial performance does not support a positive outlook for the near term. Risk factors include the company's negative cash flows and lack of profitability, which could pressure liquidity if the company fails to secure additional financing or achieve operational efficiency. The risk assessment indicates low dilution and liquidity risk, but the absence of disclosed dilution sources or financing plans limits the ability to assess future capital-raising needs. No immediate filing-based liquidity or dilution flags were detected, but the company's financial position remains fragile. Recent events include the publication of the latest financial data, which shows continued losses and negative cash flows. No recent filings or transcripts were provided that would indicate significant operational or strategic developments. The company appears to be in a development or early commercialization phase, with no disclosed major contracts or partnerships.

30-day price · SWAN+0.17 (+14.4%)
Low$1.08High$1.48Close$1.35As of13 May, 00:00 UTC
Profile
CompanyBlack Swan Graphene Inc
TickerSWAN.V
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Black Swan Graphene Inc is a specialty chemicals company focused on the production and application of graphene-based materials, primarily serving industrial and advanced materials markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Black Swan Graphene Inc operates with a highly liquid capital structure, as evidenced by a current ratio of 56.53, indicating strong short-term liquidity and minimal reliance on debt financing. The company holds $4.79 million in cash and equivalents, with no long-term debt, and a debt-to-equity ratio of 0.0, suggesting a conservative leverage profile. Despite this, the company reported negative operating and free cash flows of -$529,840 and -$406,900, respectively, indicating ongoing operational cash burn. Profitability metrics are negative, with a return on equity (ROE) of -4.88% and a return on assets (ROA) of -4.84%, both significantly below the typical performance of the specialty chemicals industry. These figures suggest the company is not generating returns for shareholders or effectively utilizing its asset base. The company's operating and net losses of -$687,760 and -$643,380, respectively, further underscore the lack of profitability. The company's revenue is not disclosed in the provided data, and no segment or geographic breakdown is available. This lack of transparency limits the ability to assess revenue concentration or geographic exposure. However, the absence of disclosed segments suggests the company may be in an early stage of development or may not have material operations beyond its core graphene business. The company's growth trajectory is unclear due to the absence of historical revenue data or forward-looking guidance. Analysts have assigned a mean price target of $2.50, with a strong buy recommendation, but this is based on limited data and does not reflect a clear path to profitability or revenue growth. The company's current financial performance does not support a positive outlook for the near term. Risk factors include the company's negative cash flows and lack of profitability, which could pressure liquidity if the company fails to secure additional financing or achieve operational efficiency. The risk assessment indicates low dilution and liquidity risk, but the absence of disclosed dilution sources or financing plans limits the ability to assess future capital-raising needs. No immediate filing-based liquidity or dilution flags were detected, but the company's financial position remains fragile. Recent events include the publication of the latest financial data, which shows continued losses and negative cash flows. No recent filings or transcripts were provided that would indicate significant operational or strategic developments. The company appears to be in a development or early commercialization phase, with no disclosed major contracts or partnerships.
Key takeaways
  • Black Swan Graphene Inc has a highly liquid balance sheet with $4.79 million in cash and no long-term debt.
  • The company is unprofitable, with a return on equity of -4.88% and a return on assets of -4.84%.
  • Analysts have assigned a strong buy rating, but the company's financial performance does not support a clear growth trajectory.
  • The company's capital structure is conservative, but its negative cash flows and lack of profitability pose operational risks.
  • No immediate liquidity or dilution risks were detected, but the company's financial position remains fragile.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income-$687.8k
Net income-$643.4k
R&D
SG&A
D&A
SBC
Operating cash flow-$529.8k
CapEx
Free cash flow-$406.9k
Total assets$13.3M
Total liabilities$96.9k
Total equity$13.2M
Cash & equivalents$4.8M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4-$229.8k-$225.3k
FY-3-$8.5M-$8.5M-$7.5M
FY-2-$4.6M-$6.1M-$5.1M
FY-1-$3.5M-$3.4M-$2.4M
FY0-$6.9M-$7.5M-$6.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$100.8k-$142.1k
FY-3$17.4M$16.7M
FY-2$13.9M$13.8M$5.3M
FY-1$10.7M$10.4M$3.0M
FY0$13.8M$13.3M$0.00
PeriodOCFCapExFCFSBC
FY-4-$74.6k
FY-3-$2.9M-$7.5M
FY-2-$3.6M-$5.1M
FY-1-$2.3M-$2.4M
FY0-$4.1M-$6.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7-$687.8k-$643.4k-$406.9k
FQ-6-$1.0M-$1.0M-$774.3k
FQ-5-$717.9k-$678.2k-$441.7k
FQ-4-$1.1M-$1.1M-$825.1k
FQ-3-$2.4M-$2.3M-$2.1M
FQ-2-$1.1M-$1.1M-$853.2k
FQ-1-$2.0M-$2.0M-$1.8M
FQ0-$1.4M-$2.1M-$1.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$13.3M$13.2M$4.8M
FQ-6$12.4M$12.2M$4.3M
FQ-5$11.7M$11.5M$3.8M
FQ-4$10.7M$10.4M$3.0M
FQ-3$15.6M$14.9M$7.9M
FQ-2$14.0M$13.8M$6.4M
FQ-1$14.0M$13.6M
FQ0$13.8M$13.3M$0.00
PeriodOCFCapExFCFSBC
FQ-7-$529.8k-$406.9k
FQ-6-$1.1M-$774.3k
FQ-5-$1.6M-$441.7k
FQ-4-$2.3M-$825.1k
FQ-3-$1.0M-$2.1M
FQ-2-$2.6M-$853.2k
FQ-1-$3.6M-$1.8M
FQ0-$4.1M-$1.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$13.2M
Net cash$4.8M
Current ratio56.5
Debt/Equity0.0
ROA-4.8%
ROE-4.9%
Cash conversion82.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSWANActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity0.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Mean price target2.50
Median price target2.50
High price target2.50
Low price target2.50
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.10
Last actual EPS-0.15
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:10 UTC#90ef2208
Market quoteclose USD 1.26 · shares 0.06B diluted
no public URL
2026-05-12 01:10 UTC#b3f76c8a
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 15:14 UTCJob: c70e07ca